ライフサイエンスコーパス: free T4

1 ease in serum T4 and T3, resulting in normal free T4 and free T3 concentrations.

2 Serum concentrations of free T4 and free T3 in patients taking phenytoin or carb

3 lationships were observed between T3, T4, or free T4 and global or regional CBF and cerebral glucose

4 In drug-treated patients, increased free T4 and T3 fractions offset the significant decrease

5 ct an increase in free hormone fractions and free T4 and T3.

6 tween maternal total T4, free T3, cord-blood free T4, and PBDEs and between maternal free T3 and PCBs

7 that if assays for thyrotropin, free T3, and free T4 are all done, knowledge of these patterns couple

8 Free T4 concentration measured by a commercial kit (1:5

9 inical tests will continue to show decreased free T4 concentrations in patients taking phenytoin or c

10 However, free T4 concentrations were significantly higher in pati

11 , triiodothyronine (T3), thyroxine (T4), and free T4 concentrations.

12 fold over the levels in fasted controls, but free T4 did not reach the levels in fed controls.

13 <.001 for both phenytoin and carbamazepine); free T4 fraction (by ultrafiltration assay) increased 65

14 vitro resulted in a significant increase in free T4 fraction and free T4 (P<.001).

15 ip between morbidity and mean serum level of free T4, i.e., a lower mean serum level of free T4 was a

16 cation for confirmation of naturally present free T4 in urine.

17 mortality: free T3 is inversely related and free T4 is positively related to the likelihood of death

18 level (0.08 to 3.99 mU per liter) and a low free T4 level (<0.86 ng per deciliter).

19 s adjusted to attain a normal thyrotropin or free T4 level (depending on the trial), with sham adjust

20 0 mIU/L in the TSH level or 25 pmol/L in the free T4 level.

21 1.33-1.49 ng/dL) compared with their native free T4 levels (1.05 ng/dL; 95% CI, 1.00-1.10 ng/dL; P <

22 mood instability is causally related to low free T4 levels and whether it can be attenuated with T4

23 For example, we estimated that maternal free T4 levels decreased 0.019 ng/dL (95% CI: -0.028, -0

24 oxine (T4), total triiodothyronine (T3), and free T4 levels were higher ( p < 0.001) in the NASH CRN

25 thyroxine (T4), 100 times the physiological-free T4 levels, 60-80% of T4 to T3 conversion in stimula

26 ender thyroid gland associated with elevated free T4 levels, elevated sedimentation rate, low radioio

27 .013) and between cognition and both TSH and free T4 levels.

28 associated with total triiodothyronine (T3), free T4, or thyroid-stimulating hormone (TSH).

29 significant increase in free T4 fraction and free T4 (P<.001).

30 ponse (thyroid-stimulating hormone, P2 =.01; free T4, P2 =.0049; vitiligo, P2 < 10(-6)), although thy

31 for phenytoin, P<.01 for carbamazepine); and free T4 remained unchanged.

32 Plasma free T4, thyroid-stimulating hormone (TSH), and 8 am cor

33 Free T4 was associated with a decrease in DXA-derived bo

34 f free T4, i.e., a lower mean serum level of free T4 was associated with more affective episodes and

35 In the lithium phase, a low level of free T4 was associated with more affective episodes and

36 T4 and a direct association with free T3 and free T4 were observed.